Robert E. Landry - 03 Feb 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**Robert E. Landry
Issuer symbol
REGN
Transactions as of
03 Feb 2023
Net transactions value
-$1,753,048
Form type
4
Filing time
07 Feb 2023, 15:09:21 UTC
Previous filing
20 Dec 2022
Next filing
29 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale $564,966 -739 -2.3% $764.50 32,105 03 Feb 2023 Direct F1
transaction REGN Common Stock Options Exercise $1,145,760 +3,000 +9.3% $381.92 35,105 03 Feb 2023 Direct F1
transaction REGN Common Stock Tax liability $1,740,604 -2,248 -6.4% $774.29 32,857 03 Feb 2023 Direct F1
transaction REGN Common Stock Sale $39,936 -51 -0.16% $783.05 32,806 06 Feb 2023 Direct F1
transaction REGN Common Stock Sale $88,623 -113 -0.34% $784.27 32,693 06 Feb 2023 Direct F1, F2
transaction REGN Common Stock Sale $61,299 -78 -0.24% $785.88 32,615 06 Feb 2023 Direct F1, F3
transaction REGN Common Stock Sale $66,848 -85 -0.26% $786.45 32,530 06 Feb 2023 Direct F1, F4
transaction REGN Common Stock Sale $45,673 -58 -0.18% $787.47 32,472 06 Feb 2023 Direct F1
transaction REGN Common Stock Sale $78,073 -99 -0.3% $788.62 32,373 06 Feb 2023 Direct F1, F5
transaction REGN Common Stock Sale $38,663 -49 -0.15% $789.05 32,324 06 Feb 2023 Direct F1
transaction REGN Common Stock Sale $7,904 -10 -0.03% $790.41 32,314 06 Feb 2023 Direct F1
transaction REGN Common Stock Sale $2,373 -3 -0.01% $791.00 32,311 06 Feb 2023 Direct F1
transaction REGN Common Stock Sale $1,587 -2 -0.01% $793.33 32,309 06 Feb 2023 Direct F1
transaction REGN Common Stock Sale $78,666 -99 -0.31% $794.61 32,210 06 Feb 2023 Direct F1, F6
transaction REGN Common Stock Sale $46,929 -59 -0.18% $795.41 32,151 06 Feb 2023 Direct F1, F7
transaction REGN Common Stock Sale $14,336 -18 -0.06% $796.43 32,133 06 Feb 2023 Direct F1, F8
transaction REGN Common Stock Sale $22,328 -28 -0.09% $797.43 32,105 06 Feb 2023 Direct F1
holding REGN Common Stock 250 03 Feb 2023 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -3,000 -79% $0.000000 800 03 Feb 2023 Common Stock 3,000 $381.92 Direct F1, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 113 shares of Company stock on February 6, 2023 at prices ranging from $784.02 to $784.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.
F3 Represents volume-weighted average price of sales of 78 shares of Company stock on February 6, 2023 at prices ranging from $785.85 to $785.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.
F4 Represents volume-weighted average price of sales of 85 shares of Company stock on February 6, 2023 at prices ranging from $786.03 to $786.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.
F5 Represents volume-weighted average price of sales of 99 shares of Company stock on February 6, 2023 at prices ranging from $788.48 to $788.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.
F6 Represents volume-weighted average price of sales of 99 shares of Company stock on February 6, 2023 at prices ranging from $794.28 to $794.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.
F7 Represents volume-weighted average price of sales of 59 shares of Company stock on February 6, 2023 at prices ranging from $795.26 to $795.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.
F8 Represents volume-weighted average price of sales of 18 shares of Company stock on February 6, 2023 at prices ranging from $796.35 to $796.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.
F9 The stock option award vests in four equal annual installments, commencing one year after the date of grant.